Self-questionnaire in Osteoporosis (NCT07067827)
Clinical Validation of a Self-questionnaire in Adults With Osteoporosis
🩺 Plain-English Summary (8th-Grade Level)
Osteoporosis is a multifactorial disease in which genetic predispositions play a key role in its development. A better understanding of family history and clinical manifestations among first- and second-degree relatives can help improve early detection and personalized care for at-risk patients. To this end, we will test a self-administered questionnaire previously developed by our research team. This questionnaire includes the main manifestations associated with rare genetic bone diseases such as osteogenesis imperfecta, hypophosphatasia, and osteopetrosis.
Who can join: Review the eligibility criteria below.
Location: CHU de Quebec-Universite Laval — Québec, Quebec
Age range: 18 Years
🧪 Interventions in This Study
- Self-administered questionnaire (OTHER)
- Family tree (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- CHU de Quebec-Universite Laval — Québec, Quebec
📞 Contact the Study Coordinator
Phone: (418) 525-4444
Email: laetitia.michou@crchudequebec.ulaval.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Osteoporosis
- Effects of Exoskeleton-Assisted Gait Training on Bone Health and Quality of Life — Englewood, Colorado
- Effects of Teriparatide (PTH) on Bone in Men and Women With Osteoporosis — Toronto, Ontario
- A Study of Romosozumab in Women With Multiple Myeloma and Osteoporosis — Basking Ridge, New Jersey
- Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI — West Orange, New Jersey
- Teriparatide (PTH) and Bone Strength in Postmenopausal Women — Toronto, Ontario
- Closing The Post Fracture Care Gap In Manitoba — Winnipeg, Manitoba
Explore by condition: All Osteoporosis clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.